 | • レポートコード：QY2207C3485 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のデノスマブの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にデノスマブの世界市場のxxx％を占める「60mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のデノスマブの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのデノスマブ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのデノスマブ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 デノスマブのグローバル主要メーカーには、Amgen、Qilu Pharmaceutical、Shandong Boan Biotech、Shanghai Mabwellなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 デノスマブ市場は、種類と用途によって区分されます。世界のデノスマブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 60mg、120mg 【用途別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - デノスマブ製品概要 - 種類別市場（60mg、120mg） - 用途別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のデノスマブ販売量予測2017-2028 - 世界のデノスマブ売上予測2017-2028 - デノスマブの地域別販売量 - デノスマブの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別デノスマブ販売量 - 主要メーカー別デノスマブ売上 - 主要メーカー別デノスマブ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（60mg、120mg） - デノスマブの種類別販売量 - デノスマブの種類別売上 - デノスマブの種類別価格 ・用途別市場規模（病院、クリニック、その他） - デノスマブの用途別販売量 - デノスマブの用途別売上 - デノスマブの用途別価格 ・北米市場 - 北米のデノスマブ市場規模（種類別、用途別） - 主要国別のデノスマブ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのデノスマブ市場規模（種類別、用途別） - 主要国別のデノスマブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のデノスマブ市場規模（種類別、用途別） - 主要国別のデノスマブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のデノスマブ市場規模（種類別、用途別） - 主要国別のデノスマブ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのデノスマブ市場規模（種類別、用途別） - 主要国別のデノスマブ市場規模（トルコ、サウジアラビア） ・企業情報 Amgen、Qilu Pharmaceutical、Shandong Boan Biotech、Shanghai Mabwell ・産業チェーン及び販売チャネル分析 - デノスマブの産業チェーン分析 - デノスマブの原材料 - デノスマブの生産プロセス - デノスマブの販売及びマーケティング - デノスマブの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - デノスマブの産業動向 - デノスマブのマーケットドライバー - デノスマブの課題 - デノスマブの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Denosumab Market
The global Denosumab market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 60 mg accounting for % of the Denosumab global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Denosumab market size is valued at US$ million in 2021, while the North America and Europe Denosumab are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Denosumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Denosumab market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Denosumab market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Denosumab market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Denosumab market.
Global Denosumab Scope and Market Size
Denosumab market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Denosumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
60 mg
120 mg
Segment by Application
Hospital
Clinic
Others
By Company
Amgen
Qilu Pharmaceutical
Shandong Boan Biotech
Shanghai Mabwell
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Denosumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 60 mg
1.2.3 120 mg
1.3 Market by Application
1.3.1 Global Denosumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Denosumab Market Perspective (2017-2028)
2.2 Denosumab Growth Trends by Region
2.2.1 Denosumab Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Denosumab Historic Market Size by Region (2017-2022)
2.2.3 Denosumab Forecasted Market Size by Region (2023-2028)
2.3 Denosumab Market Dynamics
2.3.1 Denosumab Industry Trends
2.3.2 Denosumab Market Drivers
2.3.3 Denosumab Market Challenges
2.3.4 Denosumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Denosumab Players by Revenue
3.1.1 Global Top Denosumab Players by Revenue (2017-2022)
3.1.2 Global Denosumab Revenue Market Share by Players (2017-2022)
3.2 Global Denosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Denosumab Revenue
3.4 Global Denosumab Market Concentration Ratio
3.4.1 Global Denosumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Denosumab Revenue in 2021
3.5 Denosumab Key Players Head office and Area Served
3.6 Key Players Denosumab Product Solution and Service
3.7 Date of Enter into Denosumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Denosumab Breakdown Data by Type
4.1 Global Denosumab Historic Market Size by Type (2017-2022)
4.2 Global Denosumab Forecasted Market Size by Type (2023-2028)
5 Denosumab Breakdown Data by Application
5.1 Global Denosumab Historic Market Size by Application (2017-2022)
5.2 Global Denosumab Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Denosumab Market Size (2017-2028)
6.2 North America Denosumab Market Size by Type
6.2.1 North America Denosumab Market Size by Type (2017-2022)
6.2.2 North America Denosumab Market Size by Type (2023-2028)
6.2.3 North America Denosumab Market Share by Type (2017-2028)
6.3 North America Denosumab Market Size by Application
6.3.1 North America Denosumab Market Size by Application (2017-2022)
6.3.2 North America Denosumab Market Size by Application (2023-2028)
6.3.3 North America Denosumab Market Share by Application (2017-2028)
6.4 North America Denosumab Market Size by Country
6.4.1 North America Denosumab Market Size by Country (2017-2022)
6.4.2 North America Denosumab Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Denosumab Market Size (2017-2028)
7.2 Europe Denosumab Market Size by Type
7.2.1 Europe Denosumab Market Size by Type (2017-2022)
7.2.2 Europe Denosumab Market Size by Type (2023-2028)
7.2.3 Europe Denosumab Market Share by Type (2017-2028)
7.3 Europe Denosumab Market Size by Application
7.3.1 Europe Denosumab Market Size by Application (2017-2022)
7.3.2 Europe Denosumab Market Size by Application (2023-2028)
7.3.3 Europe Denosumab Market Share by Application (2017-2028)
7.4 Europe Denosumab Market Size by Country
7.4.1 Europe Denosumab Market Size by Country (2017-2022)
7.4.2 Europe Denosumab Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Denosumab Market Size (2017-2028)
8.2 Asia-Pacific Denosumab Market Size by Type
8.2.1 Asia-Pacific Denosumab Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Denosumab Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Denosumab Market Share by Type (2017-2028)
8.3 Asia-Pacific Denosumab Market Size by Application
8.3.1 Asia-Pacific Denosumab Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Denosumab Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Denosumab Market Share by Application (2017-2028)
8.4 Asia-Pacific Denosumab Market Size by Region
8.4.1 Asia-Pacific Denosumab Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Denosumab Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Denosumab Market Size (2017-2028)
9.2 Latin America Denosumab Market Size by Type
9.2.1 Latin America Denosumab Market Size by Type (2017-2022)
9.2.2 Latin America Denosumab Market Size by Type (2023-2028)
9.2.3 Latin America Denosumab Market Share by Type (2017-2028)
9.3 Latin America Denosumab Market Size by Application
9.3.1 Latin America Denosumab Market Size by Application (2017-2022)
9.3.2 Latin America Denosumab Market Size by Application (2023-2028)
9.3.3 Latin America Denosumab Market Share by Application (2017-2028)
9.4 Latin America Denosumab Market Size by Country
9.4.1 Latin America Denosumab Market Size by Country (2017-2022)
9.4.2 Latin America Denosumab Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Denosumab Market Size (2017-2028)
10.2 Middle East & Africa Denosumab Market Size by Type
10.2.1 Middle East & Africa Denosumab Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Denosumab Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Denosumab Market Share by Type (2017-2028)
10.3 Middle East & Africa Denosumab Market Size by Application
10.3.1 Middle East & Africa Denosumab Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Denosumab Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Denosumab Market Share by Application (2017-2028)
10.4 Middle East & Africa Denosumab Market Size by Country
10.4.1 Middle East & Africa Denosumab Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Denosumab Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Denosumab Introduction
11.1.4 Amgen Revenue in Denosumab Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Company Details
11.2.2 Qilu Pharmaceutical Business Overview
11.2.3 Qilu Pharmaceutical Denosumab Introduction
11.2.4 Qilu Pharmaceutical Revenue in Denosumab Business (2017-2022)
11.2.5 Qilu Pharmaceutical Recent Developments
11.3 Shandong Boan Biotech
11.3.1 Shandong Boan Biotech Company Details
11.3.2 Shandong Boan Biotech Business Overview
11.3.3 Shandong Boan Biotech Denosumab Introduction
11.3.4 Shandong Boan Biotech Revenue in Denosumab Business (2017-2022)
11.3.5 Shandong Boan Biotech Recent Developments
11.4 Shanghai Mabwell
11.4.1 Shanghai Mabwell Company Details
11.4.2 Shanghai Mabwell Business Overview
11.4.3 Shanghai Mabwell Denosumab Introduction
11.4.4 Shanghai Mabwell Revenue in Denosumab Business (2017-2022)
11.4.5 Shanghai Mabwell Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer